André Cabrita

ORCID: 0000-0002-8023-6894
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Cardiac Imaging and Diagnostics
  • Infective Endocarditis Diagnosis and Management
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Cerebrovascular and Carotid Artery Diseases
  • Pericarditis and Cardiac Tamponade
  • Congenital Heart Disease Studies
  • Drug-Induced Adverse Reactions
  • Vasculitis and related conditions
  • Diabetes Treatment and Management
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Heart Failure Treatment and Management
  • Cardiovascular and Diving-Related Complications
  • Cardiac pacing and defibrillation studies
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiac electrophysiology and arrhythmias
  • Coronary Interventions and Diagnostics

Administração Regional de Saúde de Lisboa e Vale do Tejo
2025

Hospital de São João
2022-2024

A 53-year-old female with a medical history of multiple cardiovascular risk factors, alcoholic chronic hepatic disease (Child-Pugh B) thrombocytopenia, and severe calcified aortic stenosis was admitted for an elective transcatheter valve implantation (TAVI). After the procedure, patient hypotensive unresponsive to fluid challenge, there significant difference in blood pressure between two arms. The echocardiogram confirmed normal position function prosthetic but suggestive dissection....

10.7759/cureus.78607 article EN Cureus 2025-02-06

Ciprofloxacin is a widely used empiric antibiotic that may cause adverse reactions, including leukocytoclastic vasculitis (LCV). We present the case of 51-year-old woman diagnosed with pyelonephritis, who developed cutaneous vasculitic lesions one day after ciprofloxacin administration. The differential diagnosis was broad and included autoimmune diseases, which were ruled out through extensive testing. A skin biopsy confirmed LCV. This rare drug-induced reaction successfully managed by...

10.7759/cureus.78662 article EN Cureus 2025-02-07

Despite the frequent and often severe repolarization abnormalities seen in Takotsubo syndrome (TTS), underlying mechanism of life-threatening arrhythmias is incompletely understood, risk remains uncertain. TTS considered a potential cause acquired long QT syndrome; however, there no robust evidence that prolongation has major prognostic impact on these patients’ outcomes. Our aim was to assess prevalence clinical implications during events compare in-hospital long-term outcomes between...

10.4081/monaldi.2023.2834 article EN cc-by-nc Monaldi Archives for Chest Disease 2023-12-06

Abstract Paradoxical embolism occurs when embolic material crosses from the venous to arterial circulation through an intracardiac defect, such as a patent foramen ovale (PFO). Although rare, it may be cause of acute coronary syndrome (ACS), requiring high degree clinical suspicion for diagnosis. We report case 30-year-old man presenting in emergency department with prolonged atypical left thoracic pain, electrocardiogram showing sinus rhythm 1 mm ST-elevation inferior leads, and...

10.1093/cvr/cvac157.126 article EN Cardiovascular Research 2022-10-01

Abstract A 69-year-old male presented with typical angina while showering. He had history of CABG in 2008 (left internal mammary arterial [LIMA] to the first marginal and intermediate arteries RIMA LAD artery), preserved biventricular systolic function. On physical examination, an upper-arm blood pressure differential >20mmHg a decreased pulse amplitude on left side was found. ECG revealed sinus tachycardia RBBB, ST-segment depression inverted T-waves lateral inferior leads. Troponin...

10.1093/cvr/cvac157.119 article EN Cardiovascular Research 2022-10-01

Abstract Introduction Adult Congenital Heart Disease(ACHD) patients are an increasing population with known high risk for thromboembolic events.Validated scores uncertain in this population. Although apparently safe, data is scarce about the use of NOAC. Purpose To evaluate all on-NOAC followed ACHD outpatients clinic and observe its safety efficacy during a median follow-up 34 months (IQR 7–60 months). Major bleeding was defined according to types 3 5 BARC scale. Adverse event as ≥ 1...

10.1093/cvr/cvac157.104 article EN Cardiovascular Research 2022-10-01
Coming Soon ...